Speaker illustration

Doctor Stanley Nattel

Montreal Heart Institute, Montreal (Canada)

Dr. Nattel received his MD from McGill University in 1974 and undertook Internal Medicine and Clinical Pharmacology training at McGill between 1974 and 1978. He obtained Cardiology clinical and research training at Indiana University and University of Pennsylvania (1978-1981) before returning to McGill in 1981. In 1987, he transferred to University of Montreal and Montreal Heart Institute, where he directed the Research Center between 1990 and 2004. He is presently Paul-David Chair in Cardiovascular Electrophysiology and Director of the Electrophysiology Research Program at the Montreal Heart Institute, where he practices clinical cardiology. He is Editor in Chief of the Canadian Journal of Cardiology, Associate Editor of Cardiovascular Research, Rhythm Disorders section editor in JACC, and is on the editorial board of 13 other journals. His research focuses on clinically-relevant mechanisms of cardiac bioelectricity. He has published over 670 papers and has an h index of 135.

Keynote lecture - Atrial fibrillation and atrial cardiomyopathy: is atrial fibrillation ablation curative or just a transient remedy?

Event: ESC Congress 2020

Topic: Catheter Ablation of Arrhythmias

Session: Can We Cure Atrial Fibrillation? Success, Challenges and the Future


New insights into mechanisms of structural remodeling in the heart

Event: EHRA 2018

Topic: Miscellaneous

Session: Structural remodelling in arrhythmias


Models of functional reentry and fibrillation

Event: EHRA 2018

Topic: Arrhythmias, General – Diagnostic Methods

Session: Cardiac mapping in experimental atrial fibrillation and ventricular arrhythmias


Atrial-specific antiarrhythmic agents.


Topic: Pharmacology

Session: Pharmacological therapy in AF


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb